Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1.529 JPY | +0,39% | +1,09% | +8,83% |
Vakgebied
Aantal werknemers: 4 144
Verkoop per activiteit
JPY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Prescription Drugs
93,3
%
| 249 579 | 93,7 % | 260 235 | 93,3 % | +4,27% |
Over-the-counter Drugs
3,8
%
| 9 780 | 3,7 % | 10 628 | 3,8 % | +8,67% |
Medical Equipment
2,2
%
| 5 184 | 1,9 % | 6 257 | 2,2 % | +20,70% |
Others
0,7
%
| 1 714 | 0,6 % | 1 919 | 0,7 % | +11,96% |
Verkoop per regio
JPY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Japan
63,6
%
| 173 633 | 65,2 % | 177 373 | 63,6 % | +2,15% |
EMEA
18,8
%
| 42 899 | 16,1 % | 52 513 | 18,8 % | +22,41% |
Asia
8,6
%
| 19 813 | 7,4 % | 24 118 | 8,6 % | +21,73% |
China
7,7
%
| 27 197 | 10,2 % | 21 546 | 7,7 % | -20,78% |
Americas
1,3
%
| 2 715 | 1,0 % | 3 488 | 1,3 % | +28,47% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Takeshi Ito
CEO | Chief Executive Officer | 64 | 01-04-82 |
Kazuo Koshiji
DFI | Director of Finance/CFO | - | - |
Akira Kurokawa
CHM | Chairman | 71 | 01-04-77 |
Mika Masunari
CMP | Compliance Officer | - | - |
Minori Hara
CTO | Chief Tech/Sci/R&D Officer | - | - |
Investor Relations Contact | - | - | |
Keizo Nakada
PRN | Corporate Officer/Principal | - | - |
Ippei Kurihara
SAM | Sales & Marketing | - | - |
Tomoki Yashiki
HRO | Human Resources Officer | - | - |
Hiro Izaka
AUD | Comptroller/Controller/Auditor | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Akira Kurokawa
CHM | Chairman | 71 | 01-04-77 |
Kanoko Oishi
BRD | Director/Board Member | 63 | 01-06-15 |
Noboru Kotani
BRD | Director/Board Member | 67 | 24-06-22 |
Yutaro Shintaku
BRD | Director/Board Member | 68 | 01-06-17 |
Director/Board Member | 69 | 01-06-18 | |
Takeshi Ito
CEO | Chief Executive Officer | 64 | 01-04-82 |
Tamie Minami
BRD | Director/Board Member | 65 | 24-06-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 363 996 254 | 341 047 590 ( 93,70 %) | 12 792 169 ( 3,514 %) | 93,70 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
3 746 000 | 0.75% | 60 752 291 $ | |
EISAI CO., LTD. 0.32% | 949 500 | 0.32% | 38 997 598 $ |
737 469 | 0.20% | 7 487 007 $ | |
373 800 | 0.17% | 5 730 059 $ | |
259 040 | 0.00% | 2 664 939 $ | |
SEIKAGAKU CORPORATION 0.73% | 415 600 | 0.73% | 2 100 725 $ |
TOHO HOLDINGS CO., LTD. 0.09% | 69 050 | 0.09% | 1 666 197 $ |
QD LASER, INC. 1.06% | 444 480 | 1.06% | 1 597 657 $ |
SUZUKEN CO., LTD. 0.05% | 42 226 | 0.05% | 1 294 304 $ |
VITAL KSK HOLDINGS, INC. 0.25% | 128 474 | 0.25% | 1 066 195 $ |
Bedrijfsgegevens
Santen Pharmaceutical Co., Ltd.
Grand Front Osaka Tower A, 25/F 4-20 Ofuka-cho
530-8552, Osaka
+81 6 7664 8621
http://www.santen.co.jpBedrijven van de groep
Naam | Categorie en sector |
---|---|
Santen Oy
Santen Oy Pharmaceuticals: MajorHealth Technology Santen Oy engages in the development, research, manufacture and marketing of pharmaceuticals, over-the-counter products, and medical devices. It specializes in ophthalmic pharmaceuticals. The company was founded on February 28, 1997 and is headquartered in Tampere, Finland. |
Pharmaceuticals: Major
|
Santen Pharmaceutical Spain SL
Santen Pharmaceutical Spain SL Medical DistributorsDistribution Services Part of Santen Pharmaceutical Co., Ltd., Santen Pharmaceutical Spain SL wholesales pharmaceutical products. The private company is based in Las Rozas, Spain. |
Medical Distributors
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,83% | 3,64 mld. | |
+31,30% | 662 mld. | |
+21,96% | 546 mld. | |
-5,28% | 359 mld. | |
+17,03% | 323 mld. | |
+4,73% | 289 mld. | |
+13,68% | 234 mld. | |
+3,81% | 198 mld. | |
-10,63% | 194 mld. | |
+4,10% | 167 mld. |
- Beurs
- Aandelen
- Koers 4536
- Onderneming Santen Pharmaceutical Co., Ltd.